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Abstract
© 2016, Springer Science+Business Media New York.In order to optimize the study of the anti-
inflammatory activity of novel drugs, in the current study, we used simple in vitro test system,
which included osmotic and free radical hemolysis of human erythrocytes and human platelets
aggregation, to screen for potential anti-inflammatory activity of three newly developed (S)-
naproxen derivatives. We selected one of them (L3), which performed in in vitro tests nearly as
well as naproxen, and studied their anti-inflammatory effects on in vivo model of inflammation,
induced  by  carragenan.  L3  was  comparable  to  naproxen  in  its  anti-inflammatory  effects,
suggesting that the studied simple inexpensive in vitro tests of erythrocyte osmotic and free
radical hemolysis and human platelets aggregation could be used for pre-screening of potential
anti-inflammatory agents.
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